Document Detail

Sympathectomy exaggerates antihypertensive effect of vasopressin withdrawal.
MedLine Citation:
PMID:  7840254     Owner:  NLM     Status:  MEDLINE    
The role of sympathetic function in the mechanism of the decrease in arterial pressure that follows withdrawal of an intravenous infusion of arginine vasopressin (AVP) in spontaneously hypertensive rats (SHR) was studied by comparing this withdrawal-induced antihypertensive phenomenon (WAP) in rats with intact sympathetic function to those subjected to sympathectomy. Sympathectomy with guanethidine did not lower blood pressure significantly in either SHR or normotensive Wistar-Kyoto (WKY) rats despite a marked impairment of sympathetic function as judged by a dramatic attenuation of blood pressure responses to tyramine and by evidence of denervation supersensitivity to phenylephrine. Cessation of a 3-h intravenous infusion of AVP (20 was associated with large and prolonged decrease in pressure below preinfusion levels in SHR with intact sympathetic function: 5 h after stopping the infusion, pressure was 27 +/- 3 mmHg below preinfusion levels. In sympathectomized SHR, the decrease in pressure after cessation of the AVP infusion was much larger: 5 h after the infusion, pressure was 44 +/- 2 mmHg below preinfusion levels. In contrast to SHR, pressure returned to control levels in WKY with intact sympathetic function after withdrawal of AVP. A small but significant decrease in pressure occurred after withdrawal of AVP in sympathectomized WKY. The results are consistent with the hypothesis that withdrawal of sympathetic activity is a contributing factor or a prerequisite condition for development of a WAP.
E K Chiu; J R McNeill
Related Documents :
906864 - Capillary permeability to albumin in normotensive and spontaneously hypertensive rats.
18079484 - N epsilon-(carboxymethyl)lysine during the early development of hypertension.
7326434 - Flow-pressure relationships in newborn and infant spontaneously hypertensive rats.
2866664 - Effects of high and low sodium diets on the resistance vessels and their adrenergic vas...
3628364 - Bootstrapped potential circadian harbingers if not determinants of cardiovascular risk.
15046234 - Chronic administration of losartan, an angiotensin ii receptor antagonist, is not effec...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of physiology     Volume:  268     ISSN:  0002-9513     ISO Abbreviation:  Am. J. Physiol.     Publication Date:  1995 Jan 
Date Detail:
Created Date:  1995-02-27     Completed Date:  1995-02-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370511     Medline TA:  Am J Physiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  H1-6     Citation Subset:  IM    
Department of Pharmacology, University of Saskatchewan, Saskatoon, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arginine Vasopressin / administration & dosage,  pharmacology*
Blood Pressure / drug effects,  physiology*
Dose-Response Relationship, Drug
Hypertension / physiopathology*
Infusions, Intravenous
Phenylephrine / pharmacology
Rats, Inbred SHR
Rats, Inbred WKY
Species Specificity
Substance Withdrawal Syndrome
Sympathectomy, Chemical*
Tyramine / pharmacology
Reg. No./Substance:
113-79-1/Arginine Vasopressin; 51-67-2/Tyramine; 55-65-2/Guanethidine; 59-42-7/Phenylephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression and cellular localization of mRNA encoding the "gastric" isoform of H(+)-K(+)-ATPase alph...
Next Document:  Contractile dysfunction and abnormal Ca2+ modulation during postischemic reperfusion in rat heart.